Literature DB >> 12170379

Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.

L Sastry1, T Johnson, M J Hobson, B Smucker, K Cornetta.   

Abstract

To better characterize lentiviral vector supernatants, we compared three methods of titer assessment. These titer methods include assessment of vector RNA sequences in supernatants, DNA sequences in transduced cells, and vector expression in transduced cells (using a vector which expressed the green fluorescence protein, GFP). For analysis of RNA and DNA, we developed a real-time PCR method for detecting the lentiviral packaging sequence and used this methodology to quantitate the number of vector sequences. Vector expression was assessed by flow cytometric analysis for GFP. As functional titers (DNA and GFP expression titers) are dependent on transduction efficiency, we calculated the titer of a lentiviral vector, RRL-CMV-GFP, after transduction of 293, HeLa, or Mus dunni cells. Genomic DNA was extracted at 4 and 14 days after transduction and the number of vector DNA molecules was determined against a plasmid standard. Of the three cell lines tested, 293 cells provided the highest rate of transduction (PCR estimated DNA titer for RRL-CMV-GFP vector was 2.52 +/- 0.25 x 10(6) molecules/ml at 14 days, and 2.31 +/- 0.15 x 10(6) molecules/ml at 4 days). When titer was calculated based on GFP expression, the highest titer was also obtained on 293 cells (0.26 +/- 0.04 x 10(6) TU/ml at 14 days, and 0.24 +/- 0.03 +/- 10(6) TU/ml at 4 days). The titers obtained by GFP expression assay were approximately one log lower than those obtained by DNA analysis suggesting that variability in vector expression may underestimate titer. Measurement of RNA titers directly from vector supernatants against a plasmid standard indicated that the RNA titers are substantially higher than the DNA (approximately 10(3)-fold) and GFP titers (approximately 10(4)-fold). To show that the lentiviral probe and primers could be used for titering a variety of lentiviral vectors, we have also used the real-time PCR method to determine the DNA titers of two other HIV1 derived vectors, RRL-PGK-GFP (6.1 +/- 1.4 x 10(5) molecules/ml), and SMPU-RRE-BN (1.26 +/- 0.2 x 10(6) molecules/ml). We conclude that of the three methods tested, titers assessed by DNA analysis of transduced cells provide the most reliable estimate of functional titers as these are least likely to be influenced by factors, such as defective interfering particles and vector expression levels. The real-time PCR method described offers a reproducible method for lentiviral titering and can be applied to a wide variety of vectors, regardless of transgene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170379     DOI: 10.1038/sj.gt.3301731

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  103 in total

1.  Production of lentiviral vectors for transducing cells from the central nervous system.

Authors:  Mingjie Li; Nada Husic; Ying Lin; B Joy Snider
Journal:  J Vis Exp       Date:  2012-05-24       Impact factor: 1.355

2.  Scaffold-Mediated Static Transduction of T Cells for CAR-T Cell Therapy.

Authors:  Pritha Agarwalla; Edikan A Ogunnaike; Sarah Ahn; Frances S Ligler; Gianpietro Dotti; Yevgeny Brudno
Journal:  Adv Healthc Mater       Date:  2020-06-11       Impact factor: 9.933

3.  FHL2 protein is a novel co-repressor of nuclear receptor Nur77.

Authors:  Kondababu Kurakula; Erik van der Wal; Dirk Geerts; Claudia M van Tiel; Carlie J M de Vries
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

Review 4.  Imaging intracellular protein dynamics by spinning disk confocal microscopy.

Authors:  Samantha Stehbens; Hayley Pemble; Lyndsay Murrow; Torsten Wittmann
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

5.  Using Pulmozyme DNase treatment in lentiviral vector production.

Authors:  Aaron Shaw; Daniela Bischof; Aparna Jasti; Aaron Ernstberger; Troy Hawkins; Kenneth Cornetta
Journal:  Hum Gene Ther Methods       Date:  2012-02       Impact factor: 2.396

6.  Replication-competent lentivirus analysis of clinical grade vector products.

Authors:  Kenneth Cornetta; Jing Yao; Aparna Jasti; Sue Koop; Makhaila Douglas; David Hsu; Larry A Couture; Troy Hawkins; Lisa Duffy
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

7.  A combination HIV reporter virus system for measuring post-entry event efficiency and viral outcome in primary CD4+ T cell subsets.

Authors:  Carisa A Tilton; Caroline O Tabler; Mark B Lucera; Samantha L Marek; Aiman A Haqqani; John C Tilton
Journal:  J Virol Methods       Date:  2013-09-08       Impact factor: 2.014

8.  Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions.

Authors:  Bin Guan; Min Gao; Chen-Hsuan Wu; Tian-Li Wang; Ie-Ming Shih
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

9.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Authors:  Woori Kim; Yenarae Lee; Noah D McKenna; Ming Yi; Filip Simunovic; Yulei Wang; Benjamin Kong; Robert J Rooney; Hyemyung Seo; Robert M Stephens; Kai C Sonntag
Journal:  Neurobiol Aging       Date:  2014-01-24       Impact factor: 4.673

10.  EOS lentiviral vector selection system for human induced pluripotent stem cells.

Authors:  Akitsu Hotta; Aaron Y L Cheung; Natalie Farra; Kamal Garcha; Wing Y Chang; Peter Pasceri; William L Stanford; James Ellis
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.